본문으로 건너뛰기
← 뒤로

Breast Cancer Metastasis to a Renal Cell Carcinoma: A Comprehensive Review with Emphasis on Novel Immunohistochemical Tools.

International journal of surgical pathology 2026 p. 10668969261425683

Conde Ferreirós M, Abdulkader Sande S, Barreiro MNA, Bellas Pereira A, Ortiz Rey JA

📝 환자 설명용 한 줄

Cancer-to-cancer metastasis is an exceptionally rare phenomenon, with renal cell carcinoma (RCC) being the most commonly reported recipient tumor.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Conde Ferreirós M, Abdulkader Sande S, et al. (2026). Breast Cancer Metastasis to a Renal Cell Carcinoma: A Comprehensive Review with Emphasis on Novel Immunohistochemical Tools.. International journal of surgical pathology, 10668969261425683. https://doi.org/10.1177/10668969261425683
MLA Conde Ferreirós M, et al.. "Breast Cancer Metastasis to a Renal Cell Carcinoma: A Comprehensive Review with Emphasis on Novel Immunohistochemical Tools.." International journal of surgical pathology, 2026, pp. 10668969261425683.
PMID 41918273

Abstract

Cancer-to-cancer metastasis is an exceptionally rare phenomenon, with renal cell carcinoma (RCC) being the most commonly reported recipient tumor. According to the criteria established by Campbell et al, true cancer-to-cancer metastasis requires evidence of two distinct primary neoplasms and histologic confirmation of metastatic infiltration from one tumor into the other. Breast carcinoma metastasizing to clear cell renal cell carcinoma (clear cell RCC) is particularly uncommon, with only eight living patients reported to date. We report a rare instance of pleomorphic lobular breast carcinoma metastasizing to clear cell RCC. This report highlights the diagnostic challenges posed by such unusual metastatic presentations and the importance of thorough histopathological and immunohistochemical evaluation. A detailed review of the literature on breast cancer metastases to the kidney is also provided, with a focus on the role of emerging immunohistochemical markers in improving diagnostic accuracy. Recognition of this rare metastatic pattern is essential for guiding clinical management and therapeutic decisions.